Skip to main content
SpringerLink
Log in

CHA2DS2-VASc versus CHADS2 for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

The CHADS2 score is widely used to assess the risk of stroke in patients with atrial fibrillation (AF). Patients with score of 0 and 1 are considered ‘low risk’ and are often treated with aspirin. In a Danish Study, the CHA2DS2-VASc score was shown to identify low and high-risk subgroups among patients with CHADS2 score of 0 and 1, with annual risk ranging from 0.84 to 8.18 %. This study seeks to assess whether using CHA2DS2-VASc score will identify high-risk subset of patients with low CHADS2 scores in an American population. This pilot study examined data from our cardiology fellowship ambulatory clinics from January 2009 to May 2012 using the NCDR-PINNACLE registry. Each cardiology fellow entered patients’ data using on-line software developed by the American College of Cardiology. Among 2,048 patients followed at our clinics, 478 had AF. Of those, 161 patients had CHADS2 score of 0 (44 patients) or 1 (117 patients). Calculating the CHA2DS2-VASc score in these patients, 12 (7.4 %) had score of 0, 50 (31.1 %) had score of 1, 66(41 %) had score of 2, 31 (19.3 %) had score of 3 and 2 (1.2 %) had score of 4. Using original CHADS2 recommendation, warfarin would not be strongly recommended in any of these patients. Utilizing the CHA2DS2-VASc score, 61.5 % of the 161 patients would have a score of 2 or more signifying increased risk where anticoagulation may be indicated. Compared to CHADS2, CHA2DS2-VASc may more precisely predict the risk of stroke and anticoagulation strategy in low-risk patients with non-valvular AF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Stewart S, Hart CL, Hole DJ, McMurray JJ (2001) Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 86:516–521

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375

    Article  CAS  PubMed  Google Scholar 

  3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121:e91

    Google Scholar 

  4. Lip GY (2011) Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. J Thromb Haemost 9(Suppl 1):344–351

    Article  PubMed  Google Scholar 

  5. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870

    Article  CAS  PubMed  Google Scholar 

  6. Gallagher AM, Rietbrock S, Plumb J, van Staa TP (2008) Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 6(9):1500–1506

    Article  CAS  PubMed  Google Scholar 

  7. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272

    Article  PubMed  Google Scholar 

  8. Friberg L, Rosenqvist M, Lip GY (2012) Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 33(12):1500–1510

    Article  PubMed  Google Scholar 

  9. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY (2012) The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: a nationwide cohort study. Thromb Haemost 107(6):1172–1179. doi:10.1160/TH12-03-0175

    Article  CAS  PubMed  Google Scholar 

  10. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 57(11):e101–e198

    Article  PubMed  Google Scholar 

  11. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S (2006) Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation—executive summary. Circulation 114(7):e257–e354

    Article  PubMed  Google Scholar 

  12. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation. The task force of the management of atrial fibrillation of the European Society of Cardiology (ESC). Euro Heart J 31:2369–2429

    Article  Google Scholar 

  13. Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, Califf RM, ROCKET AF Steering Committee and Investigators (2013) Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) Study Cohorts. Circulation 127(2):224–232

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Internal Medicine, St. John Hospital and Medical Center, Wayne State University, 22101 Moross Road, 2nd Floor Cath Lab VEP, Detroit, MI, 48236, USA

    Chatchawan Piyaskulkaew, Tejwant Singh & Howard Rosman

  2. Medical Education, St. John Hospital and Medical Center, Wayne State University, Detroit, MI, USA

    Susan Szpunar & Louis Saravolatz II

Authors
  1. Chatchawan Piyaskulkaew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tejwant Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Szpunar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Louis Saravolatz II
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Howard Rosman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chatchawan Piyaskulkaew.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piyaskulkaew, C., Singh, T., Szpunar, S. et al. CHA2DS2-VASc versus CHADS2 for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry. J Thromb Thrombolysis 37, 400–403 (2014). https://doi.org/10.1007/s11239-013-0983-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-013-0983-z

Keywords

Search

Navigation